Incidencia del hiperparatiroidismo secundario en la población de hemodiálisis del Hospital de Especialidades Abel Gilbert Pontón de Guayaquil año 2013
No hay miniatura disponible
Fecha
2015
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Escuela de Medicina
Resumen
Hiperparatiroidismo secundario es una complicación frecuente en pacientes con enfermedad renal crónica (ERC) que se ha relacionado con un riesgo incrementado de patología cardiovascular. Considerando que estimar la incidencia de esta complicación podría ayudar a implementar intervenciones de salud efectiva para su prevención, se realizó un trabajo de tipo observacional descriptivo exploratorio de diseño no experimental transversal para conocer la incidencia de esta complicación entre 150 pacientes que se encontraron recibiendo hemodiálisis crónica en la unidad de diálisis de hospital “ABEL GILBERT PONTON” en la ciudad de Guayaquil en el año2013. Para el análisis estadístico se emplearon estadígrafos, frecuencias simples, y porcentajes. Los resultados mostraron que el hiperparatiroidismo secundario tuvo una incidencia de 1,37%, estos resultados muestran una incidencia más baja a lo expresado por otros estudios. El 61.4% de los pacientes con hiperparatiroidismo secundario presentaron Hiperfosfatemia. El 21.10% presento hipocalcemia. El 22,9% de los casos tuvieron niveles de PTH 3 veces por sobre el valor normal. La mayor parte de los pacientes con hiperparatiroidismo secundario tenían al momento del estudio entre 4 a 5 años con ER (41.2%). Se presentaron 17.4% de casos nuevos que se registraron en 2013. En conclusión el manejo adecuado de los pacientes con ERC, la medicación empleada de acuerdo a los análisis bioquímicos mensuales y oportunos, empleo de líquidos de diálisis con concentraciones de Ca 1.75 mmol/l, quelante de fosforo, análogos de la vitamina D (calcitriol) oral, reflejan la baja INCIDENCIA de esta patología.
The secondary hyperparathyroidism is a frequent complication in patients with chronic renal disease that has been associated recently with an increased risk of cardiovascular disease. Whereas estimating the frequency of this complication could help implement effective health interventions for prevention, we performed a descriptive observational work, non-experimental exploratory cross to determine the frequency of this complication among patients who were receiving chronic hemodialysis the hospital “ABEL GILBERT PONTON” in the Guayaquil city in 2013. For the statistical analysis employed statisticians, simple frequencies and percentages. Mostron results. Secondary hyperparathyroidism had a incidence 1.37%, these results show a lower to that expressed by other studies incidence. The most affected sex was male (62.3%). The 61.4% of patients with secondary hyperparathyroidism Hyperphosphatemia presented. The hypocalcemia. 22.9% of patients had PTH levels 3 times the normal value. Most patients with secondary hyperparathyroidism at the time of the study were 4 to 5 years of ERC (41.2%). They introduced 17.4% of new cases were recorded in 2013. In conclusion, the appropriate management of patients with CKD, the medication used according to the monthly and appropriate biochemical analyzes, use of dialysis fluid concentrations of Ca 1.75 mmol / l phosphate binder, analogues of vitamin D (calcitriol) oral, reflecting the low incidence of this disease
The secondary hyperparathyroidism is a frequent complication in patients with chronic renal disease that has been associated recently with an increased risk of cardiovascular disease. Whereas estimating the frequency of this complication could help implement effective health interventions for prevention, we performed a descriptive observational work, non-experimental exploratory cross to determine the frequency of this complication among patients who were receiving chronic hemodialysis the hospital “ABEL GILBERT PONTON” in the Guayaquil city in 2013. For the statistical analysis employed statisticians, simple frequencies and percentages. Mostron results. Secondary hyperparathyroidism had a incidence 1.37%, these results show a lower to that expressed by other studies incidence. The most affected sex was male (62.3%). The 61.4% of patients with secondary hyperparathyroidism Hyperphosphatemia presented. The hypocalcemia. 22.9% of patients had PTH levels 3 times the normal value. Most patients with secondary hyperparathyroidism at the time of the study were 4 to 5 years of ERC (41.2%). They introduced 17.4% of new cases were recorded in 2013. In conclusion, the appropriate management of patients with CKD, the medication used according to the monthly and appropriate biochemical analyzes, use of dialysis fluid concentrations of Ca 1.75 mmol / l phosphate binder, analogues of vitamin D (calcitriol) oral, reflecting the low incidence of this disease
Descripción
Palabras clave
Insuficiencia renal crónica, Hiperparatiroidismo, Diálisis renal, Epidemiología descriptiva, Hospital de Especialidades Guayaquil Dr. Abel Gilbert Pontón, Cantón Guayaquil, Ecuador